Nuvectis Pharma, Inc. (NVCT) has 3 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $1.2M. Most recent filing: Aug. 5, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 5, 2026 filed Aug. 3, 2026 | Carson Michael J. Vice President, Finance | $0 | 30,000 | +15% | No | |
|
|
||||||
| July 1, 2026 filed June 30, 2026 | Mosseri Marlio Charles 10% Owner | +$916,000 | 50,000 | +2% | No | |
|
|
||||||
| July 1, 2026 filed June 30, 2026 | BENTSUR RON Chairman & CEO | +$250,000 | 12,500 | +0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free